BALB/c mice vaccinated with Leishmania major ribosomal proteins extracts combined with CpG oligodeoxynucleotides become resistant to disease caused by a secondary parasite challenge.
about
CD4 T cell activation by B cells in human Leishmania (Viannia) infection.Development of Leishmania vaccines: predicting the future from past and present experience.Immunization Against Cutaneous Leishmaniasis by Alginate Microspheres Loaded With Autoclaved Leishmania Major (ALM) and Quillaja Saponins.Cross-protective effect of a combined L5 plus L3 Leishmania major ribosomal protein based vaccine combined with a Th1 adjuvant in murine cutaneous and visceral leishmaniasis.Toll-like receptors in leishmania infections: guardians or promoters?An antigenic domain of the Leishmania amazonensis nucleoside triphosphate diphosphohydrolase (NTPDase 1) is associated with disease progression in susceptible infected mice.
P2860
BALB/c mice vaccinated with Leishmania major ribosomal proteins extracts combined with CpG oligodeoxynucleotides become resistant to disease caused by a secondary parasite challenge.
description
2010 nî lūn-bûn
@nan
2010 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
name
BALB/c mice vaccinated with Le ...... secondary parasite challenge.
@ast
BALB/c mice vaccinated with Le ...... secondary parasite challenge.
@en
type
label
BALB/c mice vaccinated with Le ...... secondary parasite challenge.
@ast
BALB/c mice vaccinated with Le ...... secondary parasite challenge.
@en
prefLabel
BALB/c mice vaccinated with Le ...... secondary parasite challenge.
@ast
BALB/c mice vaccinated with Le ...... secondary parasite challenge.
@en
P2093
P2860
P50
P356
P1476
BALB/c mice vaccinated with Le ...... secondary parasite challenge.
@en
P2093
Carlos Alonso
Jimena Cortés
Manuel Soto
Pedro Bonay
P2860
P304
P356
10.1155/2010/181690
P577
2010-01-26T00:00:00Z